CRP and hemophagocytic syndrome: He also developed hemophagocytic lymphohistiocytosis (HLH), with pancytopenia and elevated C-reactive protein (CRP), ferritin, and triglycerides (Fig. 2B) without improvement despite multiple doses of tocilizumab and siltuximab.